AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15046404 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined massage (aromatherapy and massage)
Number of subjects: 42
Study 15046404 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 42
Study 14685830 — intervention group
Group type: EXPERIMENTAL
Intervention: X STOP Interspinous Process Distraction System
Number of subjects: 200
Study 14685830 — intervention group
Group type: COMPARATOR
Intervention: NON OP (non-operative therapy)
Number of subjects: 200
Study 10407200 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial condition of a delayed-response task
Number of subjects: 6
Study 10407200 — intervention group
Group type: COMPARATOR
Intervention: Nonspatial task with same response contingencies
Number of subjects: 6
Study 7560698 — intervention group
Group type: EXPERIMENTAL
Intervention: First physical activity program (sit-to-stand repetitions, transferring, walking, wheelchair propulsion) performed every 2 hours during the daytime, 5 days per week for 9 weeks
Number of subjects: 65
Study 7560698 — intervention group
Group type: EXPERIMENTAL
Intervention: Second physical activity program (rowing in wheelchair-accessible rowing machine, walking, wheelchair propulsion) performed once per day, three times per week for 9 weeks
Number of subjects: 65
Study 7560698 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 65
Study 2285640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 17
Study 2285640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 7307591 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin therapy
Number of subjects: 11
Study 7307591 — intervention group
Group type: COMPARATOR
Intervention: Control (no indomethacin therapy)
Number of subjects: 11
Study 30651130 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-tympanic injection of sodium thiosulfate gel in the left or right ear
Number of subjects: 13
Study 30651130 — intervention group
Group type: COMPARATOR
Intervention: Control ears (no treatment)
Number of subjects: 13
Study 28340430 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral sequential stimulation (BSS) with theta burst stimulation (TBS)
Number of subjects: 40
Study 28340430 — intervention group
Group type: COMPARATOR
Intervention: Ipsilateral facilitatory (intermittent TBS [iTBS] over non-dominant M1)
Number of subjects: 40
Study 28340430 — intervention group
Group type: COMPARATOR
Intervention: Contralateral inhibitory (continuous TBS [cTBS] over dominant M1)
Number of subjects: 40
Study 28340430 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 40
Study 26343013 — intervention group
Group type: EXPERIMENTAL
Intervention: G10 (10% crude glycerine)
Number of subjects: 90
Study 26343013 — intervention group
Group type: EXPERIMENTAL
Intervention: G5 (5% crude glycerine)
Number of subjects: 90
Study 26343013 — intervention group
Group type: COMPARATOR
Intervention: G0 (control, conventional feed)
Number of subjects: 90
Study 26343013 — intervention group
Group type: EXPERIMENTAL
Intervention: Castrated males
Number of subjects: 90
Study 26343013 — intervention group
Group type: EXPERIMENTAL
Intervention: G10
Number of subjects: 90
Study 24856433 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (after 2 hours)
Number of subjects: 1174
Study 24856433 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral feeding (after 18 hours)
Number of subjects: 1174
Study 22612913 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar fusion (N = 60)
Number of subjects: 93
Study 22612913 — intervention group
Group type: COMPARATOR
Intervention: Cognitive therapy and exercises (N = 33)
Number of subjects: 93
Study 19528286 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg PA-824
Number of subjects: 47
Study 19528286 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg PA-824
Number of subjects: 47
Study 19528286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 18086974 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy
Number of subjects: 130
Study 14674937 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen specific immunotherapy (SIT) with standardized birch pollen extract
Number of subjects: 19
Study 14674937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 12058842 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitation
Number of subjects: 20
Study 12058842 — intervention group
Group type: COMPARATOR
Intervention: Contingently responsive
Number of subjects: 20
Study 9810420 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotrophic newborns
Number of subjects: 0
Study 9810420 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of hypotrophic newborns
Number of subjects: 0
Study 9810420 — intervention group
Group type: COMPARATOR
Intervention: Mothers and newborns in both groups
Number of subjects: 0
Study 9810420 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord serum alpha-2-M concentrations
Number of subjects: 0
Study 7646570 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine sulphate 250 mg administered at 10:00 h
Number of subjects: 0
Study 7646570 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine sulphate 250 mg administered at 22:00 h
Number of subjects: 0
Study 31495672 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Intervention (EI) - Computer-Based Cognitive Rehabilitation (CBCR) training immediately after inclusion for 3 weeks (m = 19 days after stroke onset)
Number of subjects: 14
Study 31495672 — intervention group
Group type: COMPARATOR
Intervention: Late Intervention (LI) - Computer-Based Cognitive Rehabilitation (CBCR) training after a 3-week wait for 3 weeks (m = 44 days after stroke onset)
Number of subjects: 14
Study 31495672 — intervention group
Group type: COMPARATOR
Intervention: Control group (LI)
Number of subjects: 14
Study 31495672 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EI and LI)
Number of subjects: 14
Study 28514527 — intervention group
Group type: EXPERIMENTAL
Intervention: Robenacoxib (2.0 mg/kg SC injection prior to surgery and for 2 additional days postoperatively)
Number of subjects: 317
Study 28514527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (SC injection prior to surgery and for 2 additional days postoperatively)
Number of subjects: 317
Study 28514527 — intervention group
Group type: EXPERIMENTAL
Intervention: Robenacoxib
Number of subjects: 317
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (with exopolysaccharides)
Number of subjects: 18
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (without exopolysaccharides)
Number of subjects: 18
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt
Number of subjects: 18
Study 26001091 — intervention group
Group type: COMPARATOR
Intervention: Reference meal
Number of subjects: 18
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage (with and without exopolysaccharides)
Number of subjects: 18
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran-based beverage
Number of subjects: 18
Study 26001091 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of microbial exopolysaccharides
Number of subjects: 18
Study 23811267 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over left DLPFC
Number of subjects: 11
Study 23811267 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 11
Study 19823807 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (Neurobloc)
Number of subjects: 9
Study 19823807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 18210765 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus rosiglitazone
Number of subjects: 41
Study 18210765 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus metformin
Number of subjects: 41
Study 18210765 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 41
Study 15811762 — intervention group
Group type: EXPERIMENTAL
Intervention: Stylet group (n = 109)
Number of subjects: 216
Study 15811762 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 107)
Number of subjects: 216
Study 12037435 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose botulinum toxin (BTX) treatment (mean total target dose of 547 +/- 113 mouse units)
Number of subjects: 31
Study 12037435 — intervention group
Group type: COMPARATOR
Intervention: 4-times-diluted preparation (130 +/- 32 MU)
Number of subjects: 31
Study 9988391 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro culture of dissected testicular biopsy samples at 37 degrees C for up to 96 hours.
Number of subjects: 10
Study 9988391 — intervention group
Group type: EXPERIMENTAL
Intervention: Incubation of immotile testicular spermatozoa in pentoxifylline and 2‐deoxyadenosine for 30 minutes.
Number of subjects: 10
Study 9988391 — intervention group
Group type: COMPARATOR
Intervention: Culture of tissue blocks.
Number of subjects: 10
Study 7486097 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine (4 micrograms/kg in 10 mL) infused in 20 min followed by a 2-micrograms.kg-1.h-1 infusion (5 mL/h) during 12 h (Group 1)
Number of subjects: 40
Study 7486097 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil (0.5 microgram/kg in 10 mL) in 20 min followed by a 0.25-microgram.kg-1.h-1 infusion (5 mL/h) during 12 h (Group 2)
Number of subjects: 40
Study 2137971 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin, 400 and 800 micrograms administered intranasally
Number of subjects: 0
Study 2137971 — intervention group
Group type: COMPARATOR
Intervention: Danazol, 600 and 800 mg
Number of subjects: 0
Study 2137971 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin
Number of subjects: 0
Study 6770408 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.45 ml/kg
Number of subjects: 24
Study 6770408 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.90 ml/kg
Number of subjects: 24
Study 6770408 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation (26 h)
Number of subjects: 24
Study 6770408 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined alcohol (0.45 ml/kg and 0.90 ml/kg) and sleep deprivation (26 h)
Number of subjects: 24
Study 6770408 — intervention group
Group type: COMPARATOR
Intervention: Control (0 ml/kg alcohol and no sleep deprivation)
Number of subjects: 24
Study 30370852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fomentex herbal tea 11.2 g/day in 2 divided doses for 2 weeks
Number of subjects: 40
Study 30370852 — intervention group
Group type: COMPARATOR
Intervention: Medroxy progesterone acetate (MP) 10 mg/day for the last 10 days of their menstrual cycles
Number of subjects: 40
Study 30370852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fomentex herbal tea
Number of subjects: 40
Study 30370852 — intervention group
Group type: COMPARATOR
Intervention: Medroxy progesterone acetate (MP)
Number of subjects: 40
Study 30370852 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 30545748 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol ingestion (approximately 2 standard drinks)
Number of subjects: 23
Study 30545748 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (nonalcoholic)
Number of subjects: 23
Study 28962586 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment intensification (methotrexate + tapered high-dose prednisone)
Number of subjects: 610
Study 26189118 — intervention group
Group type: EXPERIMENTAL
Intervention: Iterative image reconstruction (IR) with 30% tube current reduction
Number of subjects: 400
Study 26189118 — intervention group
Group type: COMPARATOR
Intervention: Standard filtered back projection (FBP) image reconstruction with standard tube current
Number of subjects: 400
Study 23665027 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg QD
Number of subjects: 43
Study 23665027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 20646706 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast health promotion program (120-min duration including education, film, instruction, booklet, calendar, card)
Number of subjects: 190
Study 20646706 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast health promotion program
Number of subjects: 190
Study 20646706 — intervention group
Group type: COMPARATOR
Intervention: Control group (general information except breast health)
Number of subjects: 190
Study 20646706 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190
Study 19250050 — intervention group
Group type: EXPERIMENTAL
Intervention: Ga‐As laser therapy combined with a 12‐wk comprehensive home exercise program
Number of subjects: 44
Study 19250050 — intervention group
Group type: COMPARATOR
Intervention: 12‐wk comprehensive home exercise program alone
Number of subjects: 44
Study 19250050 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 17374703 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with increased IMT (mean IMT 1.6 +/- 0.6)
Number of subjects: 208
Study 17374703 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (mean IMT 0.3 +/- 0.1)
Number of subjects: 208
Study 17374703 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with hypertension (mean IMT 0.475 +/- 0.03 mm)
Number of subjects: 208
Study 15719220 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.3 mg/kg)
Number of subjects: 24
Study 15719220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 12486586 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 4630
Study 12486586 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring at stage C
Number of subjects: 4630
Study 12486586 — intervention group
Group type: COMPARATOR
Intervention: Narcotrend monitoring at stage F
Number of subjects: 4630
Study 9814462 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 (levothyroxine) treatment (21 patients, 2.7 +/- 0.3 microg/kg, TSH < 0.3 microIU/mL)
Number of subjects: 45
Study 9814462 — intervention group
Group type: COMPARATOR
Intervention: Placebo (24 patients)
Number of subjects: 45
Study 9814462 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 (levothyroxine) treatment
Number of subjects: 45
Study 7665802 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 50
Study 7665802 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 50
Study 7665802 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy
Number of subjects: 50
Study 7665802 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without depression)
Number of subjects: 50
Study 2473363 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chemo‐radiotherapy [2 X (COPP + ABVD) + 40 Gy extended field irradiation (EF)]
Number of subjects: 226
Study 2473363 — intervention group
Group type: COMPARATOR
Intervention: Combined chemo‐radiotherapy [2 X (COPP + ABVD) + 20 Gy EF]
Number of subjects: 226
Study 2473363 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy [3 X (COPP + ABVD)]
Number of subjects: 226
Study 2473363 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy [1 X (COPP + ABVD)]
Number of subjects: 226
Study 2473363 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage therapy (radiotherapy in case of persisting nodal disease; chemotherapy with 4 X CEVD in case of persisting disseminated disease)
Number of subjects: 226
Study 132915 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6
Study 132915 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 6
Study 31943055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (interpersonal counseling, community mobilization, mass media campaigns)
Number of subjects: 8565
Study 31943055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention
Number of subjects: 8565
Study 31943055 — intervention group
Group type: COMPARATOR
Intervention: Nonintensive intervention
Number of subjects: 8565
Study 29845833 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF stretching combined with electrostimulation (TENS)
Number of subjects: 30
Study 29845833 — intervention group
Group type: COMPARATOR
Intervention: PNF stretching with voluntary contraction (Control)
Number of subjects: 30
Study 28584913 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.0625 mg
Number of subjects: 24
Study 28584913 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 24
Study 28584913 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.250 mg
Number of subjects: 24
Study 28584913 — intervention group
Group type: COMPARATOR
Intervention: Placebo (T0)
Number of subjects: 24
Study 26895618 — intervention group
Group type: EXPERIMENTAL
Intervention: 35-mm follicles
Number of subjects: 30
Study 26895618 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-mm follicles
Number of subjects: 30
Study 26895618 — intervention group
Group type: EXPERIMENTAL
Intervention: Impending ovulation follicles
Number of subjects: 30
Study 26895618 — intervention group
Group type: COMPARATOR
Intervention: 40-mm and impending ovulation follicles
Number of subjects: 30
Study 26895618 — intervention group
Group type: COMPARATOR
Intervention: Impending ovulation group
Number of subjects: 30
Study 24899762 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP (n = 34)
Number of subjects: 65
Study 24899762 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP (n = 31)
Number of subjects: 65
Study 22218384 — intervention group
Group type: EXPERIMENTAL
Intervention: Humeral head resurfacing
Number of subjects: 7
Study 22218384 — intervention group
Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 7
Study 19285307 — intervention group
Group type: COMPARATOR
Intervention: Standard antiseptic measures
Number of subjects: 1032
Study 19285307 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive antiseptic measures
Number of subjects: 1032
Study 19285307 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapses in discipline
Number of subjects: 1032
Study 19285307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal anastomosis
Number of subjects: 1032
Study 19285307 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of operation more than 3 hours
Number of subjects: 1032
Study 19285307 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index >30 kg/m2
Number of subjects: 1032
Study 17461726 — intervention group
Group type: EXPERIMENTAL
Intervention: (32)P‐chromic phosphate colloids (32)P‐CP) administered via multipointed infiltrative injection
Number of subjects: 190
Study 17461726 — intervention group
Group type: COMPARATOR
Intervention: Control group (simple operative group without (32)P‐CP injection)
Number of subjects: 190
Study 16602632 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment for two months
Number of subjects: 0
Study 16602632 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin treatment
Number of subjects: 0
Study 16602632 — intervention group
Group type: COMPARATOR
Intervention: Normocholesterolemic controls
Number of subjects: 0
Study 12414556 — intervention group
Group type: EXPERIMENTAL
Intervention: High anxiety as a stable trait and personality traits such as high novelty seeking and low harm avoidance.
Number of subjects: 521
Study 12414556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton Depression Scale and STAI-X2 for anxiety measurement.
Number of subjects: 521
Study 12414556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tridimensional Personality Questionnaire.
Number of subjects: 521
Study 10456462 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 55
Study 10456462 — intervention group
Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 55
Study 10456462 — intervention group
Group type: COMPARATOR
Intervention: Control group (coronary angioplasty alone)
Number of subjects: 55
Study 7604799 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg once daily for 4 weeks, then 40 mg twice daily for 12 weeks
Number of subjects: 134
Study 7604799 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg once daily for 4 weeks, then 40 mg once daily for 12 weeks
Number of subjects: 134
Study 2227077 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ketorolac given orally every 6 h for up to 7 days
Number of subjects: 40
Study 2227077 — intervention group
Group type: COMPARATOR
Intervention: 50 mg pentazocine given orally every 6 h for up to 7 days
Number of subjects: 40
Study 452941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefruside (25 mg daily)
Number of subjects: 42
Study 452941 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100–400 mg daily)
Number of subjects: 42
Study 31908162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic heart disease (IHD)
Number of subjects: 30946
Study 31908162 — intervention group
Group type: COMPARATOR
Intervention: Non-ischaemic heart disease (non-IHD)
Number of subjects: 30946
Study 31945586 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion (1 ng/kg/min)
Number of subjects: 46
Study 31945586 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 46
Study 30114658 — intervention group
Group type: EXPERIMENTAL
Intervention: oxaliplatin-fluoropyrimidine chemotherapy with cetuximab
Number of subjects: 2183
Study 30114658 — intervention group
Group type: COMPARATOR
Intervention: oxaliplatin-fluoropyrimidine chemotherapy
Number of subjects: 2183
Study 27734441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combat Ready Clamp (CRoC)
Number of subjects: 84
Study 27734441 — intervention group
Group type: EXPERIMENTAL
Intervention: SAM® Junctional Tourniquet (SJT)
Number of subjects: 84
Study 24762768 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelclair® mouthwash used 3 times a day
Number of subjects: 57
Study 24762768 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 57
Study 23018166 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 30
Study 23018166 — intervention group
Group type: COMPARATOR
Intervention: Placebo Reiki
Number of subjects: 30
Study 20226404 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cystectomy with the vasopressin injection technique
Number of subjects: 15